Tyra Biosciences (TYRA) Total Liabilities (2020 - 2026)

Tyra Biosciences (TYRA) has 7 years of Total Liabilities data on file, last reported at $24.5 million in Q1 2026.

• Quarterly Total Liabilities rose 22.68% year-over-year to $24.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.5 million (up 22.68% YoY) and the FY2025 annual result came in at $23.4 million, up 14.82% from the prior year.
• Total Liabilities grew to $24.5 million in Q1 2026, from $23.4 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $24.5 million in Q1 2026 to a low of $6.3 million in Q1 2023.
• A 5-year average of $15.7 million and a median of $16.4 million in 2024 frame the typical range for Total Liabilities.
• The widest YoY moves for Total Liabilities: up 158.56% in 2023, down 19.55% in 2023.
• Tracing TYRA's Total Liabilities over 5 years: stood at $8.4 million in 2022, then surged by 158.56% to $21.6 million in 2023, then decreased by 5.5% to $20.4 million in 2024, then grew by 14.82% to $23.4 million in 2025, then increased by 4.41% to $24.5 million in 2026.
• The last three Total Liabilities figures came in at $24.5 million (Q1 2026), $23.4 million (Q4 2025), and $21.3 million (Q3 2025), per Business Quant data.